Published June 2012 | Version public
Journal Article

Selection of Pharmaceutical Antioxidants by Hydrodynamic Voltammetry

  • 1. ROR icon Abbott (United States)
  • 2. ROR icon California Institute of Technology
  • 3. ROR icon Thermo Fisher Scientific (United States)

Abstract

Antioxidant compounds are routinely included in pharmaceutical formulations in order to minimize the oxidative degradation of the active pharmaceutical ingredient(s) (API). The effectiveness of the antioxidants being considered is often assessed by creating several formulations with the API(s) and single or multiple antioxidants in order to place each of these formulations on stability under accelerated conditions. This trial and error selection process is costly and time consuming, often taking weeks before the oxidation is observed at a detectable level. Using a flow injection coulometric detector based system, a potential tool has been developed to guide initial antioxidant selection for hindering the oxidative degradation for a given drug substance in its formulation environment. The relative potential for the API to be oxidized can be measured by matching the conditions of the coulometric experiment to the formulation matrix. Using this selection criterion, the choice of antioxidants to study for individual formations can be greatly narrowed, thus leading to a significant savings in development time and cost.

Additional Information

© 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. Issue online: 4 June 2012; Version of record online: 9 May 2012; Manuscript Accepted: 7 April 2012; Manuscript Received: 2 February 2012.

Additional details

Identifiers

Eprint ID
75669
Resolver ID
CaltechAUTHORS:20170404-082006891

Dates

Created
2017-04-04
Created from EPrint's datestamp field
Updated
2021-11-15
Created from EPrint's last_modified field